Delivery Order SPE2DB24D2212-SPE2DB25FHPPN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count) with a contract value of $3,046.18. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 units, with a ceiling value of $1,344.57. This competitively awarded, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Janumet XR 100-1,000 mg tablets (30-count units) with a contract ceiling value of $1,824.14. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by January 6, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180 count) with a ceiling value of $5,490.37. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 4, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count) with a ceiling value of $1,746.19. This firm fixed price delivery order, which is not set-aside and represents a competitively awarded contract, is scheduled for completion by July 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Janumet XR 100-1,000 mg tablets (90-count units) with a ceiling value of $1,522.98. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a contract ceiling value of $2,762.89. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This delivery order, valued at approximately $39,906, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of JANUMET XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order, valued at $29,236.05, represents a competitive award with no set-aside designation and a completion date of June 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHPPNDelivery Order
This delivery order, awarded on April 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 units, valued at $4,538.74 with a firm fixed price structure. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract involves no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion target date of April 24, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Janumet XR delivery represents routine pharmaceutical fulfillment under the broader medical supply chain structure, where AmerisourceBergen maintains demonstrated capability to meet federal requirements across varied therapeutic domains through multiple competitively awarded delivery orders ranging significantly in value.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/23/25 |